Cargando…
Targeting triple‐negative breast cancer with an aptamer‐functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies
BACKGROUND: Areas of hypoxia are often found in triple-negative breast cancer (TNBC), it is thus more difficult to treat than other types of breast cancer, and may require combination therapies. A new strategy that combined bioreductive therapy with photodynamic therapy (PDT) was developed herein to...
Autores principales: | Chou, Yi-Te, Lin, Chih-Yu, Wen, Jyun-Wei, Hung, Ling-Chun, Chang, Ying-Feng, Yang, Chia-Min, Wu, Li-chen, Ho, Ja-an Annie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008604/ https://www.ncbi.nlm.nih.gov/pubmed/33781277 http://dx.doi.org/10.1186/s12951-021-00786-8 |
Ejemplares similares
-
Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy
por: He, Xi, et al.
Publicado: (2018) -
Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy
por: Dong, Yunxia, et al.
Publicado: (2022) -
Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer
por: Bahman, Fatemah, et al.
Publicado: (2021) -
Nanoformulation of Tetrapyrroles Derivatives in Photodynamic Therapy: A Focus on Bacteriochlorin
por: Pallavi, Pragya, et al.
Publicado: (2022) -
Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145.
por: Bremner, J. C., et al.
Publicado: (1992)